MARKET INTRODUCTION
Chronic Kidney Disease is also known as chronic kidney failure. CKD is best described as the gradual failure of kidney functions. Kidneys perform important functions like filtering out waste from body, removing excess of fluid from blood, performs osmoregulation. But in CKD body wastes, excess of electrolytes, dangerous level of fluids build up in body and can give severe complications. Symptoms of CKD are, vomiting, loss of appetite, nausea, changes in urination, weakness. CKD drugs are the agents which are used in treatment of chronic kidney disease.
MARKET DYNAMICS
The key market drivers for Chronic Kidney Disease Drugs Market Includes, increasing prevalence of kidney diseases and cardiovascular diseases along with rising incidences of diabetes, intestinal infections. Moreover, R&D investments by pharmaceutical companies to develop, launch novel therapies for treatment of chronic diseases is also expected to fuel market growth. Additionally, lifestyle factors such as, smoking, obesity are also boosting market growth. Whereas, less awareness about CKD and side effects from treatment are expected to restrain market growth.
MARKET SCOPE
The "Chronic Kidney Disease Drugs Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Chronic Kidney Disease Drugs market with detailed market segmentation by drug class, distribution channel and end user. The Chronic Kidney Disease Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Chronic Kidney Disease Drugs Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Chronic Kidney Disease Drugs Market is segmented on the basis of drug class, distribution channel and end user. On the basis of drug class the market is segmented as, ACE inhibitors, Angiotensin -II receptor blocker, beta blockers, calcium channel blockers, diuretics. On the basis of distribution channel the market is segmented as, hospital pharmacies, retail pharmacies, others. And on the basis of end user the market is segmented as, hospital, specialty clinics, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Chronic Kidney Disease Drugs Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Chronic Kidney Disease Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Chronic Kidney Disease Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Chronic Kidney Disease Drugs Market in these regions.
MARKET PLAYERS
The report covers key developments in the Chronic Kidney Disease Drugs Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Chronic Kidney Disease Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Chronic Kidney Disease Drugs market in the global market. Below mentioned is the list of few companies engaged in the Chronic Kidney Disease Drugs Market.
The report also includes the profiles of key players in Chronic Kidney Disease Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
AstraZeneca
Pfizer, Inc.
Amgen Inc.
Fibrogen, Inc.
GlaxoSmithKline plc.
F. Hoffmann -La Roche
AbbVie Inc.
Akebia Therapeutics, Inc.
Teva Pharmaceutical Industries, Ltd.
Johnson and Johnson Services, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chronic Kidney Disease Drugs Market - By Drug Class
1.3.2 Chronic Kidney Disease Drugs Market - By Distribution Channel
1.3.3 Chronic Kidney Disease Drugs Market - By End User
1.3.4 Chronic Kidney Disease Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHRONIC KIDNEY DISEASE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHRONIC KIDNEY DISEASE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHRONIC KIDNEY DISEASE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. CHRONIC KIDNEY DISEASE DRUGS - GLOBAL MARKET OVERVIEW
6.2. CHRONIC KIDNEY DISEASE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CHRONIC KIDNEY DISEASE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ACE INHIBITORS
7.3.1. Overview
7.3.2. ACE Inhibitors Market Forecast and Analysis
7.4. ANGIOTENSIN-II RECEPTOR BLOCKERS
7.4.1. Overview
7.4.2. Angiotensin-II receptor blockers Market Forecast and Analysis
7.5. BETA-BLOCKERS
7.5.1. Overview
7.5.2. Beta-blockers Market Forecast and Analysis
7.6. CALCIUM CHANNEL BLOCKERS
7.6.1. Overview
7.6.2. Calcium channel blockers Market Forecast and Analysis
7.7. DIURETICS
7.7.1. Overview
7.7.2. Diuretics Market Forecast and Analysis
7.8. ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)
7.8.1. Overview
7.8.2. Erythropoiesis-stimulating agents (ESAs) Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. CHRONIC KIDNEY DISEASE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CHRONIC KIDNEY DISEASE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. SPECIALTY CLINICS
9.4.1. Overview
9.4.2. Specialty Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. CHRONIC KIDNEY DISEASE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Chronic Kidney Disease Drugs Market Overview
10.1.2 North America Chronic Kidney Disease Drugs Market Forecasts and Analysis
10.1.3 North America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.5 North America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Chronic Kidney Disease Drugs Market
10.1.6.1.1 United States Chronic Kidney Disease Drugs Market by Drug Class
10.1.6.1.2 United States Chronic Kidney Disease Drugs Market by Distribution Channel
10.1.6.1.3 United States Chronic Kidney Disease Drugs Market by End User
10.1.6.2 Canada Chronic Kidney Disease Drugs Market
10.1.6.2.1 Canada Chronic Kidney Disease Drugs Market by Drug Class
10.1.6.2.2 Canada Chronic Kidney Disease Drugs Market by Distribution Channel
10.1.6.2.3 Canada Chronic Kidney Disease Drugs Market by End User
10.1.6.3 Mexico Chronic Kidney Disease Drugs Market
10.1.6.3.1 Mexico Chronic Kidney Disease Drugs Market by Drug Class
10.1.6.3.2 Mexico Chronic Kidney Disease Drugs Market by Distribution Channel
10.1.6.3.3 Mexico Chronic Kidney Disease Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Chronic Kidney Disease Drugs Market Overview
10.2.2 Europe Chronic Kidney Disease Drugs Market Forecasts and Analysis
10.2.3 Europe Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.5 Europe Chronic Kidney Disease Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Chronic Kidney Disease Drugs Market
10.2.6.1.1 Germany Chronic Kidney Disease Drugs Market by Drug Class
10.2.6.1.2 Germany Chronic Kidney Disease Drugs Market by Distribution Channel
10.2.6.1.3 Germany Chronic Kidney Disease Drugs Market by End User
10.2.6.2 France Chronic Kidney Disease Drugs Market
10.2.6.2.1 France Chronic Kidney Disease Drugs Market by Drug Class
10.2.6.2.2 France Chronic Kidney Disease Drugs Market by Distribution Channel
10.2.6.2.3 France Chronic Kidney Disease Drugs Market by End User
10.2.6.3 Italy Chronic Kidney Disease Drugs Market
10.2.6.3.1 Italy Chronic Kidney Disease Drugs Market by Drug Class
10.2.6.3.2 Italy Chronic Kidney Disease Drugs Market by Distribution Channel
10.2.6.3.3 Italy Chronic Kidney Disease Drugs Market by End User
10.2.6.4 Spain Chronic Kidney Disease Drugs Market
10.2.6.4.1 Spain Chronic Kidney Disease Drugs Market by Drug Class
10.2.6.4.2 Spain Chronic Kidney Disease Drugs Market by Distribution Channel
10.2.6.4.3 Spain Chronic Kidney Disease Drugs Market by End User
10.2.6.5 United Kingdom Chronic Kidney Disease Drugs Market
10.2.6.5.1 United Kingdom Chronic Kidney Disease Drugs Market by Drug Class
10.2.6.5.2 United Kingdom Chronic Kidney Disease Drugs Market by Distribution Channel
10.2.6.5.3 United Kingdom Chronic Kidney Disease Drugs Market by End User
10.2.6.6 Rest of Europe Chronic Kidney Disease Drugs Market
10.2.6.6.1 Rest of Europe Chronic Kidney Disease Drugs Market by Drug Class
10.2.6.6.2 Rest of Europe Chronic Kidney Disease Drugs Market by Distribution Channel
10.2.6.6.3 Rest of Europe Chronic Kidney Disease Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Chronic Kidney Disease Drugs Market Overview
10.3.2 Asia-Pacific Chronic Kidney Disease Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.5 Asia-Pacific Chronic Kidney Disease Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Chronic Kidney Disease Drugs Market
10.3.6.1.1 Australia Chronic Kidney Disease Drugs Market by Drug Class
10.3.6.1.2 Australia Chronic Kidney Disease Drugs Market by Distribution Channel
10.3.6.1.3 Australia Chronic Kidney Disease Drugs Market by End User
10.3.6.2 China Chronic Kidney Disease Drugs Market
10.3.6.2.1 China Chronic Kidney Disease Drugs Market by Drug Class
10.3.6.2.2 China Chronic Kidney Disease Drugs Market by Distribution Channel
10.3.6.2.3 China Chronic Kidney Disease Drugs Market by End User
10.3.6.3 India Chronic Kidney Disease Drugs Market
10.3.6.3.1 India Chronic Kidney Disease Drugs Market by Drug Class
10.3.6.3.2 India Chronic Kidney Disease Drugs Market by Distribution Channel
10.3.6.3.3 India Chronic Kidney Disease Drugs Market by End User
10.3.6.4 Japan Chronic Kidney Disease Drugs Market
10.3.6.4.1 Japan Chronic Kidney Disease Drugs Market by Drug Class
10.3.6.4.2 Japan Chronic Kidney Disease Drugs Market by Distribution Channel
10.3.6.4.3 Japan Chronic Kidney Disease Drugs Market by End User
10.3.6.5 South Korea Chronic Kidney Disease Drugs Market
10.3.6.5.1 South Korea Chronic Kidney Disease Drugs Market by Drug Class
10.3.6.5.2 South Korea Chronic Kidney Disease Drugs Market by Distribution Channel
10.3.6.5.3 South Korea Chronic Kidney Disease Drugs Market by End User
10.3.6.6 Rest of Asia-Pacific Chronic Kidney Disease Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Chronic Kidney Disease Drugs Market by Drug Class
10.3.6.6.2 Rest of Asia-Pacific Chronic Kidney Disease Drugs Market by Distribution Channel
10.3.6.6.3 Rest of Asia-Pacific Chronic Kidney Disease Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Chronic Kidney Disease Drugs Market Overview
10.4.2 Middle East and Africa Chronic Kidney Disease Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.5 Middle East and Africa Chronic Kidney Disease Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Chronic Kidney Disease Drugs Market
10.4.6.1.1 South Africa Chronic Kidney Disease Drugs Market by Drug Class
10.4.6.1.2 South Africa Chronic Kidney Disease Drugs Market by Distribution Channel
10.4.6.1.3 South Africa Chronic Kidney Disease Drugs Market by End User
10.4.6.2 Saudi Arabia Chronic Kidney Disease Drugs Market
10.4.6.2.1 Saudi Arabia Chronic Kidney Disease Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia Chronic Kidney Disease Drugs Market by Distribution Channel
10.4.6.2.3 Saudi Arabia Chronic Kidney Disease Drugs Market by End User
10.4.6.3 U.A.E Chronic Kidney Disease Drugs Market
10.4.6.3.1 U.A.E Chronic Kidney Disease Drugs Market by Drug Class
10.4.6.3.2 U.A.E Chronic Kidney Disease Drugs Market by Distribution Channel
10.4.6.3.3 U.A.E Chronic Kidney Disease Drugs Market by End User
10.4.6.4 Rest of Middle East and Africa Chronic Kidney Disease Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Chronic Kidney Disease Drugs Market by Drug Class
10.4.6.4.2 Rest of Middle East and Africa Chronic Kidney Disease Drugs Market by Distribution Channel
10.4.6.4.3 Rest of Middle East and Africa Chronic Kidney Disease Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Chronic Kidney Disease Drugs Market Overview
10.5.2 South and Central America Chronic Kidney Disease Drugs Market Forecasts and Analysis
10.5.3 South and Central America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.5 South and Central America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Chronic Kidney Disease Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Chronic Kidney Disease Drugs Market
10.5.6.1.1 Brazil Chronic Kidney Disease Drugs Market by Drug Class
10.5.6.1.2 Brazil Chronic Kidney Disease Drugs Market by Distribution Channel
10.5.6.1.3 Brazil Chronic Kidney Disease Drugs Market by End User
10.5.6.2 Argentina Chronic Kidney Disease Drugs Market
10.5.6.2.1 Argentina Chronic Kidney Disease Drugs Market by Drug Class
10.5.6.2.2 Argentina Chronic Kidney Disease Drugs Market by Distribution Channel
10.5.6.2.3 Argentina Chronic Kidney Disease Drugs Market by End User
10.5.6.3 Rest of South and Central America Chronic Kidney Disease Drugs Market
10.5.6.3.1 Rest of South and Central America Chronic Kidney Disease Drugs Market by Drug Class
10.5.6.3.2 Rest of South and Central America Chronic Kidney Disease Drugs Market by Distribution Channel
10.5.6.3.3 Rest of South and Central America Chronic Kidney Disease Drugs Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHRONIC KIDNEY DISEASE DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMGEN INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. FIBROGEN, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ABBVIE INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AKEBIA THERAPEUTICS, INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON SERVICES, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. AstraZeneca
2. Pfizer Inc
3. Amgen Inc
4. FibroGen, Inc
5. GlaxoSmithKline plc
6. F. Hoffmann-La Roche
7. AbbVie Inc.
8. Akebia Therapeutics, Inc
9. Teva Pharmaceutical Industries Ltd
10. Johnson and Johnson Services, Inc.
Global Prescription Dermatology Therapeu..
Dermatological therapeutics are pharmaceuticals that specifi..
+1-646-791 7070US (Toll Free)